Safety Rates Drug Report: CLINDAMYCIN HCL 150 MG CAPSULE AUROB INDO PHARM Skin discolouration adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: CLINDAMYCIN HCL 150 MG CAPSULE AUROB INDO PHARM Injury: Skin discolouration Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 1 Number of Pages: 1

DRUGNAME	PT	EventCount
CLINDAMYCIN HCL 150 MG CAPSULE AUROB INDO PHARM	Skin discolouration	1

|< 1/2 << Previous Page Page 1

Total Records: 1 Number of Pages: 1

Execution Time: 0.0033960342407227 seconds (ucode:5317187). Developed by: James D. Barger